Figures & data
Table 1. Non-genetic secondary causes of low LDL cholesterol.
Table 2. Summary of the epidemiology, genetic, and clinical features of the primary causes of low LDL cholesterol.
Table 3. Treatment and clinical follow-up of patients with monogenic hypocholesterolemia: abetalipoproteinemia, homozygous familial hypobetalipoproteinemia, and chylomicron retention disease.
Tabara Y, Ueshima H, Takashima N, et al. Mendelian randomization analysis in three Japanese populations supports a causal role of alcohol consumption in lowering low-density lipid cholesterol levels and particle numbers. Atherosclerosis. 2016;254:242–248. Wang F, Zheng J, Yang B, et al. Effects of vegetarian diets on blood lipids: a systematic review and meta‐analysis of randomized controlled trials. J Am Heart Assoc. 2015;4:e002408. Hartman C, Tamary H, Tamir A, et al. Hypocholesterolemia in children and adolescents with β-thalassemia intermedia. J Pediatr. 2002;141:543–547. Giovannini I, Boldrini G, Chiarla C, et al. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients. Intensive care Med. 1999;25:748–751. Obialo CI, Okonofua EC, Nzerue MC, et al. Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure. Kidney Int. 1999;56:1058–1063. Shalev H, Kapelushnik J, Moser A, et al. Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am J Hematol. 2007;82:199–202. Zwickl H, Hackner K, Köfeler H, et al. Reduced LDL-cholesterol and reduced total cholesterol as potential indicators of early cancer in male treatment-naïve cancer patients with pre-cachexia and cachexia. Front Oncol. 2020;10:1262. Nowak JK, Szczepanik M, Wojsyk-Banaszak I, et al. Cystic fibrosis dyslipidaemia: a cross-sectional study. J Cyst Fibros. 2019;18:566–571. Ginsberg H, Grabowski GA, Gibson JC, et al. Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease. Clin Genet. 1984;26:109–116. Iseki K, Yamazato M, Tozawa M, et al. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 2002;61:1887–1893. Rizos CV. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76–84. Bonville DA, Parker TS, Levine DM, et al. The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome. Surg Infect. 2004;5:39–49. Yalcinkaya A, Unal S, Oztas Y. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased apolipoprotein A1 is linked to inflammation. Lipids Health Dis. 2019;18:225. Zorca S, Freeman L, Hildesheim M, et al. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol. 2010;149:436–445. Flores MS, Obregón-Cárdenas A, Tamez E, et al. Hypocholesterolemia in patients with an amebic liver abscess. Gut Liver. 2014;8:415–420. Bima AI, Hooper AJ, van Bockxmeer FM, et al. Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia. Ann Clin Biochem. 2009;46:420–422. Shor-Posner G, Basit A, Lu Y, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am j med. 1993;94:515–519. Lal CS, Kumar A, Kumar S, et al. Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis. Clin Chim Acta. 2007;382:151–153. Moutzouri E, Elisaf M, Liberopoulos N. Hypocholesterolemia. Curr Vasc Pharmacol. 2011;9:200–212. Wilson DE, Birchfield GR, Hejazi JS, et al. Hypocholesterolemia in patients treated with recombinant interleukin-2: appearance of remnant-like lipoproteins. J Clin Oncol. 1989;7:1573–1577. Bassen FA, Kornzweig AL. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood. 1950;5:381–387.